Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Regency Centers
REG
$14.1B
| $3.47M | 0.01% |
+64,479
| New | +$3.6M |
|
|
GNMK
1502
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.47M | 0.01% |
386,891
+313,339
| +426% | +$3.37M |
|
|
CBM
1503
DELISTED
Cambrex Corporation
CBM
| $3.46M | 0.01% |
185,503
+127,731
| +221% | +$2.74M |
|
1504
CSX Corp
CSX
$95.2B
| $3.46M | 0.01% |
+323,679
| New | +$3.34M |
|
1505
GameStop
GME
$8.09B
| $3.46M | 0.01% |
335,592
-287,792
| -46% | -$3.06M |
|
|
1506
Mastercard
MA
$524B
| $3.46M | 0.01% |
46,738
-1,369,023
| -97% | -$104M |
|
1507
Trex
TREX
$4.78B
| $3.45M | 0.01% |
399,312
-14,120
| -3% | -$118K |
|
|
LORL
1508
DELISTED
Loral Space and Communications, Inc.
LORL
| $3.45M | 0.01% |
47,993
-69,651
| -59% | -$5.13M |
|
1509
LeMaitre Vascular
LMAT
$1.82B
| $3.44M | 0.01% |
500,000
| – | – |
|
1510
FS KKR Capital
FSK
$3.32B
| $3.42M | 0.01% |
79,360
-36,785
| -32% | -$1.54M |
|
|
SRCI
1511
DELISTED
SRC Energy Inc
SRCI
| $3.41M | 0.01% |
279,865
+241,851
| +636% | +$3.02M |
|
1512
Booz Allen Hamilton
BAH
$8.96B
| $3.41M | 0.01% |
145,658
+93,672
| +180% | +$2.06M |
|
1513
CALL
D.R. Horton
DHI
$41.7B
| $3.41M | 0.01% |
166,100
| – | – |
|
1514
Pediatrix Medical
MD
$2.18B
| $3.4M | 0.01% |
62,056
+44,718
| +258% | +$2.54M |
|
|
CLVS
1515
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.4M | 0.01% |
+75,000
| New | +$3.13M |
|
|
MNTA
1516
PUT
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.4M | 0.01% |
300,000
+109,900
| +58% | +$1.25M |
|
1517
Nektar Therapeutics
NKTR
$2.53B
| $3.4M | 0.01% |
18,767
-8,579
| -31% | -$1.64M |
|
|
SQBK
1518
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
| $3.39M | 0.01% |
176,367
+146,944
| +499% | +$2.79M |
|
1519
Stagwell
STGW
$2.13B
| $3.39M | 0.01% |
176,662
+134,984
| +324% | +$2.84M |
|
1520
Revvity
RVTY
$13.9B
| $3.38M | 0.01% |
77,591
-210,461
| -73% | -$9.58M |
|
1521
PUT
RH
RH
$2.7B
| $3.38M | 0.01% |
42,500
+18,600
| +78% | +$1.55M |
|
|
HA
1522
DELISTED
Hawaiian Holdings, Inc.
HA
| $3.37M | 0.01% |
250,302
+195,385
| +356% | +$2.82M |
|
1523
STAG Industrial
STAG
$7.14B
| $3.36M | 0.01% |
162,196
+149,564
| +1,184% | +$3.45M |
|
|
IPHS
1524
DELISTED
Innophos Holdings, Inc.
IPHS
| $3.35M | 0.01% |
60,849
+21,394
| +54% | +$1.24M |
|
|
XCO
1525
DELISTED
Exco Resources
XCO
| $3.35M | 0.01% |
66,838
+39,125
| +141% | +$2.74M |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.